epocrates logo
epocrates logo
epocrates logo
  • 0

Government Health Agency News

FDA

Presence of glass particle prompts Veklury recall

September 25, 2024

card-image

Gilead announced that it's issuing a voluntary recall of one lot of Veklury (remdesivir) 100 mg/vial. The company received a customer complaint and confirmed the presence of a glass particle in the vial during an investigation. To date, Gilead hasn't received any reports of adverse events related to this recall. Tap for more details ...

Trending icon

TRENDING THIS WEEK

EPOCRATES CME

View Catalog

view all CME activities
learn more about epocrates plus
Clinical FAQ icon

Clinical FAQs

Check out the answers to frequently asked questions about our clinical content.

Download Epocrates from the App StoreDownload Epocrates from the Play Store
About UsFeaturesBusiness SolutionsHelp & Feedback
© 2026 epocrates, Inc.   Terms of UsePrivacy PolicyEditorial PolicyDo Not Sell or Share My Information